Publicação: Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi
dc.contributor.author | Trossini, Gustavo H. G. | |
dc.contributor.author | Malvezzi, Alberto | |
dc.contributor.author | T-do Amaral, Antonia | |
dc.contributor.author | Rangel-Yagui, Carlota Oliveira | |
dc.contributor.author | Izidoro, Mario A. | |
dc.contributor.author | Cezari, Maria Helena S. | |
dc.contributor.author | Juliano, Luiz | |
dc.contributor.author | Chin, Chung Man [UNESP] | |
dc.contributor.author | Menezes, Carla M. S. | |
dc.contributor.author | Ferreira, Elizabeth Igne | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2014-05-20T13:24:56Z | |
dc.date.available | 2014-05-20T13:24:56Z | |
dc.date.issued | 2010-02-01 | |
dc.description.abstract | Nitrofurazone (NF) and its derivative, hydroxymethylnitrofurazone (NFOH), have presented antichagasic activity. NFOH has higher activity and lower mutagenicity. The aim of this work was to assess whether NF and its derivative NFOH would also be inhibitors of cruzain, besides their trypanothione reductase inhibitory activity. In vitro cruzain inhibition tests were performed for both compounds, and the 50% inhibitory concentration (IC(50)) for NF and NFOH presented values of 22.83 +/- 1.2 mu M and 10.55 +/- 0.81 mu M, respectively. AM1 semi-empirical molecular modeling studies were performed to understand the activity of the compounds, corroborating the observed cruzain inhibitory activity. | en |
dc.description.affiliation | Univ São Paulo, Fac Ciencias Farmaceut, Dept Farm, BR-05508900 São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Dept Quim Fundamental, Inst Quim, BR-05508900 São Paulo, Brazil | |
dc.description.affiliation | Univ Fed São Paulo, Escola Paulista Med, INFAR, Dept Biofis, São Paulo, Brazil | |
dc.description.affiliation | Univ Estadual Paulista, Fac Ciencias Farmaceut, São Paulo, Brazil | |
dc.description.affiliationUnesp | Univ Estadual Paulista, Fac Ciencias Farmaceut, São Paulo, Brazil | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
dc.description.sponsorship | PROBRAL | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorship | PRP-USP Procontes | |
dc.description.sponsorshipId | FAPESP: 01/01192-3 | |
dc.description.sponsorshipId | FAPESP: 04/06097-7 | |
dc.description.sponsorshipId | FAPESP: 02/09518-8 | |
dc.format.extent | 62-67 | |
dc.identifier | http://dx.doi.org/10.3109/14756360902941058 | |
dc.identifier.citation | Journal of Enzyme Inhibition and Medicinal Chemistry. Abingdon: Taylor & Francis Ltd, v. 25, n. 1, p. 62-67, 2010. | |
dc.identifier.doi | 10.3109/14756360902941058 | |
dc.identifier.issn | 1475-6366 | |
dc.identifier.lattes | 9734333607975413 | |
dc.identifier.orcid | 0000-0003-4141-0455 | |
dc.identifier.uri | http://hdl.handle.net/11449/7864 | |
dc.identifier.wos | WOS:000275000900008 | |
dc.language.iso | eng | |
dc.publisher | Taylor & Francis Ltd | |
dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | |
dc.relation.ispartofjcr | 3.638 | |
dc.relation.ispartofsjr | 1,040 | |
dc.rights.accessRights | Acesso restrito | |
dc.source | Web of Science | |
dc.subject | Chagas' | en |
dc.subject | disease | en |
dc.subject | cruzain inhibitory activity | en |
dc.subject | molecular modeling | en |
dc.subject | nitrofurazone derivative | en |
dc.subject | Trypanosoma cruzi | en |
dc.title | Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi | en |
dc.type | Artigo | |
dcterms.license | http://informahealthcare.com/userimages/ContentEditor/1255620309227/Copyright_And_Permissions.pdf | |
dcterms.rightsHolder | Taylor & Francis Ltd | |
dspace.entity.type | Publication | |
unesp.author.lattes | 9734333607975413[8] | |
unesp.author.orcid | 0000-0003-4141-0455[8] | |
unesp.author.orcid | 0000-0003-3634-2531[1] | |
unesp.author.orcid | 0000-0003-4221-9505[4] | |
unesp.author.orcid | 0000-0003-2087-033X[10] | |
unesp.author.orcid | 0000-0002-5589-2822[7] | |
unesp.author.orcid | 0000-0003-2937-5255[3] | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquara | pt |
unesp.department | Fármacos e Medicamentos - FCF | pt |
Arquivos
Licença do Pacote
1 - 2 de 2
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: